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A 75-year-old woman, 50-pack-year ex-smoker presented with a lung nodule on a routine follow-up chest computed 
tomography scan for prior colon adenocarcinoma (Fig. 1A). A 
resection revealed an apparently single 1.5-cm nodule on gross 
examination. Microscopic examination revealed an adenocar-
cinoma of lung origin, as supported by morphology (Fig. 1B) 
and diffusely positive immunohistochemistry for TTF-1 and 
Napsin A. The tumor consisted of two geographically contigu-
ous areas—a 6-mm area with solid and acinar patterns, and 
a peripheral 9-mm area with a predominantly lepidic pattern 
(Fig. 1C, D). Although the two areas could represent hetero-
geneous histology in a single adenocarcinoma, the dumbbell 
shape of the lesion raised the possibility of a collision of two 
immediately adjacent separate tumors. The two areas were dis-
sected out and submitted for EGFR and KRAS molecular test-
ing separately. Sequencing revealed a KRAS G12A mutation 
in the 6-mm area, and a novel KRAS L19F/T20S double muta-
tion in the 9-mm area (Fig. 2A). The latter was confirmed to 
represent same-allele double mutation—a complex compound 
substitution (L19_T20>FS)—by next-generation sequencing 
(Fig. 2B), resulting in potential functional cooperativity based 
on amino acid modeling (Fig. 3). Overall, these molecular 
data established that the 6-mm and 9-mm areas had distinct 
KRAS mutations, thus representing two colliding synchronous 
primaries rather than histologically heterogeneous areas of a 
single adenocarcinoma.
This case illustrates a rare phenomenon of collision 
tumors, in which two distinct tumors co-occur at the same or 
immediately adjacent anatomic locations.1 The exact incidence 
of collision of synchronous lung carcinomas is unknown, but 
given that 18% of patients with lung cancer have multiple pri-
mary tumors,2 the odds of two tumors occurring immediately 
adjacent to each other are not negligible. As illustrated here, 
collisions are inapparent on radiologic and gross examination. 
Although microscopic examination is generally effective at 
identifying collisions of different tumor types, recognition of 
this phenomenon for synchronous lung adenocarcinomas is 
challenging because these tumors are at baseline highly het-
erogeneous (i.e., composed of a mixture of lepidic, acinar, 
solid, and other patterns), making it difficult to distinguish 
histologic heterogeneity in a single adenocarcinoma from 
two colliding, contiguous tumors. Peripheral lepidic pattern 
is commonly seen in lung adenocarcinomas. In this case, a 
dumbbell-shaped outline of the lesion raised the possibility 
of a collision, but a definitive distinction between a single 
morphologically heterogeneous adenocarcinoma versus a col-
lision could not be made based on microscopic findings. This 
case demonstrates the utility of driver mutation analysis in 
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FIGURE 1. A, Chest computed tomography scan: appar-
ently single nodule (arrow) with solid and ground-glass com-
ponents. B, Low-power and (C, D) higher-power microscopic 
images of H&E-stained section, revealing two geographically 
contiguous areas with distinct growth patterns—solid and 
acinar (6-mm area) and predominantly lepidic (9-mm area). 
Although this could represent histologic heterogeneity in 
a single adenocarcinoma, the dumbbell-shaped outline of 
the lesion raised the possibility of a collision of two separate 
primary tumors. H&E, hematoxylin and eosin. 
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elucidating tumor clonal relationships in the setting of a pos-
sible collision, similar to what has been recently proposed for 
the utility of molecular profiling for the distinction of synchro-
nous/metachronous primaries from intrapulmonary metasta-
ses.3 We also illustrated the use of next-generation sequencing 
to determine that the two KRAS mutations in the 9-mm nodule 
resided on the same allele, thus excluding the possibility they 
were a result of yet another unsuspected collision of tumors 
with distinct KRAS mutations.
In the era of predictive molecular testing, collision may be 
an under-recognized, albeit rare, cause for aberrant driver muta-
tion profiles in lung adenocarcinomas. Specifically, although 
there is strong evidence that major driver mutations in EGFR 
and KRAS are distributed homogeneously throughout individ-
ual tumors, there are a number of reports to the contrary. One 
explanation for such findings has been geographic variability in 
mutant to wild-type allele ratio resulting from variable ampli-
fication of the mutant allele and/or variable admixture of non-
neoplastic cells, leading to inconsistent detection of mutations 
with lower sensitivity methods (i.e., mutation “pseudoheteroge-
neity”).4,5 This case illustrates another potential mechanism for 
mutation pseudoheterogeneity. In our case, random microdissec-
tion with a presumption that all dissected samples were derived 
from a single tumor would have resulted in the impression of 
intratumoral heterogeneity of KRAS mutations. Alternatively, 
molecular testing of the conglomerate nodule in the absence of 
microdissection would have resulted in “pseudomultiplicity” of 
KRAS G12A and L19F/T20S mutations. In contradistinction, 
the L19F/T20S double mutation illustrates a rare example of 
true, functionally significant mutation multiplicity.
FIGURE 2.  Sanger sequencing 
electropherograms, revealing a 
KRAS G12A(c.35G>C) mutation 
in the 6-mm nodule (A) and KRAS 
L19F(c.57G>T)/T20S(c.58A>T) 
double mutation in the 9-mm nodule 
(B). C, Split-screen view of aligned 
sequencing reads visualized using 
the IGV. Sequencing was performed 
on a PGM Ion Torrent sequencer and 
aligned with Ion Reporter software 
(Life Technologies, Carlsbad, CA). 
Alignments of reads at exon 2 of the 
KRAS gene (displayed here in reverse 
sequence, corresponding to posi-
tion 25,398,252 to 25,398,296 of 
chromosome 12), are represented as 
gray polygons with bases not match-
ing the reference sequence indicated 
in color. Individual base mismatches 
with respect to the reference 
sequence are displayed in orange 
for KRAS_35[G>C] and green for 
KRAS_57-58[CT>AA]. The sequence 
reads from the 9-mm tumor show 
that L19F and T20S reside on 
the same reads and therefore the 
same KRAS allele. IGV, Integrative 
Genomics Viewer; WT, wild type.
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In summary, this case illustrates unsuspected collision 
of synchronous primary lung adenocarcinomas as a previously 
unreported potential cause of aberrant molecular findings, and 
highlights the importance of careful histologic examination of 
tissue submitted for molecular testing.
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FIGURE 3.  Amino acid modeling of KRAS L19F/T20S 
(L19_T20>FS) double mutation. L19F and T20S are highly 
conserved and belong to the core region of KRAS. L19 is 
predicted to interact with GTP/GDP-binding residues (N116, 
A146, and K16 that in turn interact with F28) and T20 with 
the aromatic ring of Y40. Together, bulky substitution of phe-
nylalanine (L19F) and a smaller serine (T20S) likely cooperate 
to distort the KRAS core in the vicinity of the GTP/GDP bind-
ing site thus shifting equilibrium toward the active “on” state. 
